These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4909863)

  • 21. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma.
    Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D
    Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846
    [No Abstract]   [Full Text] [Related]  

  • 22. Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program.
    Rossi A; Bonadonna G; Valagussa P; Veronesi U
    Recent Results Cancer Res; 1977; (62):134-42. PubMed ID: 341246
    [No Abstract]   [Full Text] [Related]  

  • 23. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
    Penttilä O; Ikkala E
    Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antitumor polychemotherapy].
    Alberto P
    Poumon Coeur; 1968; 24(1):21-6. PubMed ID: 5652203
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of a new 5-fluorouracil derivative, BOF-A2, in advanced non-small cell lung cancer. A multi-center phase II study.
    Nakai Y; Furuse K; Ohta M; Yamaguchi Y; Fujii M; Asakawa M; Fukuoka M; Yoshida K; Niitani H
    Acta Oncol; 1994; 33(5):523-6. PubMed ID: 7917366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Our experiences with polychemotherapy of malignant endothoracic tumors (103 cases)].
    Molina C; Cheminat JC; Passemard N; Adam J
    Poumon Coeur; 1968; 24(1):103-9. PubMed ID: 4968015
    [No Abstract]   [Full Text] [Related]  

  • 28. A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.
    Kovach JS; Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
    Oncology; 1974; 29(1):34-9. PubMed ID: 4837137
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
    Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
    Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
    [No Abstract]   [Full Text] [Related]  

  • 30. 5-Fluorouracil in the treatment of gastrointestinal neoplasia.
    Kaufman S
    N Engl J Med; 1973 Jan; 288(4):199-201. PubMed ID: 4264581
    [No Abstract]   [Full Text] [Related]  

  • 31. [Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
    Horton J; Olson K
    Poumon Coeur; 1968; 24(1):59-62. PubMed ID: 4968016
    [No Abstract]   [Full Text] [Related]  

  • 32. Sequential chemotherapy of advanced colorectal cancer with standard or high-dose methotrexate followed by 5-fluorouracil.
    Solan A; Vogl SE; Kaplan BH; Berenzweig M; Richard J; Lanham R
    Med Pediatr Oncol; 1982; 10(2):145-9. PubMed ID: 7040929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immediate results of polychemotherapy of patients with 3-4 stage lung cancer].
    Kasianenko IV; Ierusalimskii EL; Omelchenko AT
    Vrach Delo; 1973 Feb; 2():61-3. PubMed ID: 4722333
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experiences with the cytostatic drug natulan].
    Kohout J
    Med Klin; 1969 May; 64(19):898-901. PubMed ID: 5819002
    [No Abstract]   [Full Text] [Related]  

  • 35. [A clinicopathological study on preoperative anticancer chemotherapy for gastric cancer (author's transl)].
    Honda H
    Nihon Geka Hokan; 1978 May; 47(3):333-63. PubMed ID: 354546
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase-II study of Navelbine in advanced breast cancer.
    Canobbio L; Boccardo F; Pastorino G; Brema F; Martini C; Resasco M; Santi L
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):33-6. PubMed ID: 2711204
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemo immunotherapy of advanced breast cancer with BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Buzdar A; Burgess MA; Richman SP; Tashima CK; Schwarz M; Hersh EM
    Recent Results Cancer Res; 1977; (62):143-50. PubMed ID: 601328
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of carcinoma of the lung with 1-acetyl-2-picolinoylhydrazine (NSC-68626).
    Wilson KS; Ricci JA; Grobmyer AJ
    Cancer Chemother Rep; 1970 Aug; 54(4):243-4. PubMed ID: 4946008
    [No Abstract]   [Full Text] [Related]  

  • 40. Radiotherapy plus 5-FU compared to radiotherapy alone for inoperable and unresectable bronchogenic carcinoma.
    Carr DT; Childs DS; Lee RE
    Cancer; 1972 Feb; 29(2):375-80. PubMed ID: 4622422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.